Pay in 4 interest-free payments of $6.17 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Although nausea and reduced food intake can occur with some GLP-1 receptor agonists, many studies showed reduced alcohol and drug-seeking behaviors even when substances were administered intravenously, suggesting the effects go beyond simple appetite suppression
Tirzepatide takes this a step further by also activating GIP receptors, making it a dual-action injectable that targets hunger from two hormonal pathways simultaneously
"It's studies like this that we hope will definitely move the needle on (insurance) coverage." Less than a fifth of large companies in the U.S
C.et al (2015)
-self-injecting-GLP-1-prefilled-pens.jpeg?width=1200&height=900&fit=crop)
US$ 21.23
US$ 22.18
US$ 27.39
